Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 107

1.

Somatic mosaicism in Fanconi anemia: molecular basis and clinical significance.

Lo Ten Foe JR, Kwee ML, Rooimans MA, Oostra AB, Veerman AJ, van Weel M, Pauli RM, Shahidi NT, Dokal I, Roberts I, Altay C, Gluckman E, Gibson RA, Mathew CG, Arwert F, Joenje H.

Eur J Hum Genet. 1997 May-Jun;5(3):137-48.

PMID:
9272737
2.

Assessment of mitomycin C sensitivity in Fanconi anemia complementation group C gene (Fac) knock-out mouse cells.

Otsuki T, Wang J, Demuth I, Digweed M, Liu JM.

Int J Hematol. 1998 Apr;67(3):243-8.

PMID:
9650445
3.

DNA cross-linker-induced G2/M arrest in group C Fanconi anemia lymphoblasts reflects normal checkpoint function.

Heinrich MC, Hoatlin ME, Zigler AJ, Silvey KV, Bakke AC, Keeble WW, Zhi Y, Reifsteck CA, Grompe M, Brown MG, Magenis RE, Olson SB, Bagby GC.

Blood. 1998 Jan 1;91(1):275-87.

4.

Fanconi anemia in Tunisia: high prevalence of group A and identification of new FANCA mutations.

Bouchlaka C, Abdelhak S, Amouri A, Ben Abid H, Hadiji S, Frikha M, Ben Othman T, Amri F, Ayadi H, Hachicha M, Rebaï A, Saad A, Dellagi K; Tunisian Fanconi Anemia Study Group.

J Hum Genet. 2003;48(7):352-61. Epub 2003 Jun 24.

PMID:
12827451
5.

Association of complementation group and mutation type with clinical outcome in fanconi anemia. European Fanconi Anemia Research Group.

Faivre L, Guardiola P, Lewis C, Dokal I, Ebell W, Zatterale A, Altay C, Poole J, Stones D, Kwee ML, van Weel-Sipman M, Havenga C, Morgan N, de Winter J, Digweed M, Savoia A, Pronk J, de Ravel T, Jansen S, Joenje H, Gluckman E, Mathew CG.

Blood. 2000 Dec 15;96(13):4064-70.

6.

Hypomorphic mutations in the gene encoding a key Fanconi anemia protein, FANCD2, sustain a significant group of FA-D2 patients with severe phenotype.

Kalb R, Neveling K, Hoehn H, Schneider H, Linka Y, Batish SD, Hunt C, Berwick M, Callen E, Surralles J, Casado JA, Bueren J, Dasi A, Soulier J, Gluckman E, Zwaan CM, van Spaendonk R, Pals G, de Winter JP, Joenje H, Grompe M, Auerbach AD, Hanenberg H, Schindler D.

Am J Hum Genet. 2007 May;80(5):895-910. Epub 2007 Apr 6. Erratum in: Am J Hum Genet. 2007 Jul;81(1):196.

7.

Detection of somatic mosaicism and classification of Fanconi anemia patients by analysis of the FA/BRCA pathway.

Soulier J, Leblanc T, Larghero J, Dastot H, Shimamura A, Guardiola P, Esperou H, Ferry C, Jubert C, Feugeas JP, Henri A, Toubert A, Socié G, Baruchel A, Sigaux F, D'Andrea AD, Gluckman E.

Blood. 2005 Feb 1;105(3):1329-36. Epub 2004 Sep 21.

8.

Subtyping analysis of Fanconi anemia by immunoblotting and retroviral gene transfer.

Pulsipher M, Kupfer GM, Naf D, Suliman A, Lee JS, Jakobs P, Grompe M, Joenje H, Sieff C, Guinan E, Mulligan R, D'Andrea AD.

Mol Med. 1998 Jul;4(7):468-79.

9.

Normal expression of the Fanconi anemia proteins FAA and FAC and sensitivity to mitomycin C in two patients with Seckel syndrome.

Abou-Zahr F, Bejjani B, Kruyt FA, Kurg R, Bacino C, Shapira SK, Youssoufian H.

Am J Med Genet. 1999 Apr 23;83(5):388-91.

PMID:
10232749
10.

Functional correction of Fanconi anemia group A hematopoietic cells by retroviral gene transfer.

Fu KL, Foe JR, Joenje H, Rao KW, Liu JM, Walsh CE.

Blood. 1997 Nov 1;90(9):3296-303.

11.

Molecular characterization of three novel Fanconi anemia mutations in Israeli Arabs.

Tamary H, Dgany O, Toledano H, Shalev Z, Krasnov T, Shalmon L, Schechter T, Bercovich D, Attias D, Laor R, Koren A, Yaniv I.

Eur J Haematol. 2004 May;72(5):330-5.

PMID:
15059067
12.

Fanconi anemia group A and D cell lines respond normally to inhibitors of cell cycle regulation.

Johnstone P, Reifsteck C, Kohler S, Worland P, Olson S, Moses RE.

Somat Cell Mol Genet. 1997 Nov;23(6):371-7.

PMID:
9661700
13.

Reverse mosaicism in Fanconi anemia: natural gene therapy via molecular self-correction.

Gross M, Hanenberg H, Lobitz S, Friedl R, Herterich S, Dietrich R, Gruhn B, Schindler D, Hoehn H.

Cytogenet Genome Res. 2002;98(2-3):126-35.

PMID:
12697994
14.

Bone marrow failure in the Fanconi anemia group C mouse model after DNA damage.

Carreau M, Gan OI, Liu L, Doedens M, McKerlie C, Dick JE, Buchwald M.

Blood. 1998 Apr 15;91(8):2737-44.

15.

Cytogenetic sensitivity of G0 lymphocytes of Fanconi anemia patients and obligate carriers to mitomycin C and ionizing radiation.

Mohseni-Meybodi A, Mozdarani H, Vosough P.

Cytogenet Genome Res. 2007;119(3-4):191-5. doi: 10.1159/000112060. Epub 2008 Feb 1.

PMID:
18253028
16.

Interaction of FANCD2 and NBS1 in the DNA damage response.

Nakanishi K, Taniguchi T, Ranganathan V, New HV, Moreau LA, Stotsky M, Mathew CG, Kastan MB, Weaver DT, D'Andrea AD.

Nat Cell Biol. 2002 Dec;4(12):913-20.

PMID:
12447395
17.
18.

Identification of Alu-mediated deletions in the Fanconi anemia gene FAA.

Levran O, Doggett NA, Auerbach AD.

Hum Mutat. 1998;12(3):145-52.

PMID:
9711872
19.

Functional correction of fanconi anemia group C hematopoietic cells by the use of a novel lentiviral vector.

Yamada K, Olsen JC, Patel M, Rao KW, Walsh CE.

Mol Ther. 2001 Apr;3(4):485-90.

20.

Phenotypic correction of Fanconi anemia group C knockout mice.

Gush KA, Fu KL, Grompe M, Walsh CE.

Blood. 2000 Jan 15;95(2):700-4.

Supplemental Content

Support Center